The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Aortic Valve Replacement Devices Market By 2030 Based On Its 2026 Value?

The aortic valve replacement devices market has experienced significant growth in recent years. It is anticipated to increase from $8.85 billion in 2025 to $9.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.2%. Historically, this expansion has been driven by an aging population with valvular diseases, the broadening of cardiac surgery capabilities, a rise in the diagnosis of aortic stenosis, the early adoption of surgical valve replacements, and advancements in cardiovascular imaging.

The market for aortic valve replacement devices is projected to experience substantial expansion over the coming years. By 2030, its valuation is anticipated to reach $14.51 billion, growing at a compound annual growth rate (CAGR) of 10.4%. This projected increase during the forecast period stems from factors such as a greater inclination towards transcatheter procedures, increased financial commitments to structural heart initiatives, a rising need for outpatient cardiac interventions, the broader application of advanced biomaterials, and improved procedural success rates. Key developments foreseen in this period encompass the growing adoption of minimally invasive valve replacement, wider utilization of transcatheter valve technologies, an escalating demand for self-expandable valves, the proliferation of patient-specific valve designs, and a heightened emphasis on the long-term durability of valves.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33017&type=smp

What Important Drivers Are Powering The Aortic Valve Replacement Devices Market Growth?

The expanding volume of valve replacement procedures is anticipated to fuel the progress of the aortic valve replacement devices market in the foreseeable future. These surgeries are medical interventions aimed at mending or substituting impaired heart valves to re-establish proper blood circulation and enhance heart performance. The surge in valve replacement surgeries, largely attributable to the growing prevalence of age-associated heart valve conditions, is creating a greater need for surgical solutions to address declining valve functionality and avert complications. Aortic valve replacement devices facilitate these procedures by allowing for safer and more efficacious valve repair or replacement, thereby enhancing patient outcomes and promoting broader surgical implementation. As an illustration, in June 2025, information from the British Heart Foundation, a UK-based cardiovascular research charity, indicates that in the United Kingdom during 2022/23, more than 13,034 aortic valve replacement (AVR) and almost 7,695 transcatheter aortic valve implantation (TAVI) procedures were carried out. The rise in TAVI procedures highlights the increasing embrace of less invasive valve replacement techniques. Consequently, the expanding volume of valve replacement operations is stimulating the advancement of the aortic valve replacement devices market.

What Key Segment Areas Are Included In The Aortic Valve Replacement Devices Market Assessment?

The aortic valve replacement devices market covered in this report is segmented –

1) By Product: Balloon-Expandable; Self-Expandable; Mechanically Expandable; Aortic Regurgitation

2) By Leaflet Material: Bovine Pericardium; Porcine Pericardium

3) By Frame Material: Cobalt-Chromium; Nitinol

4) By End-Use: Inpatient Facilities; Outpatient Facilities

Subsegments:

1) By Balloon-Expandable: Balloon Pre-Dilation; Balloon Post-Dilation; Balloon Valves

2) By Self-Expandable: Supra-Annular Valves; Intra-Annular Valves; Resheathable Valves

3) By Mechanically Expandable: Mechanically Adjustable Valves; Radial Force Valves; Repositionable Valves

4) By Aortic Regurgitation: Surgical Valve Replacement; Transcatheter Valve Replacement; Repair Devices

Which Trends Are Shaping The Aortic Valve Replacement Devices Market Landscape?

Major companies operating in the aortic valve replacement devices market are prioritizing advanced innovations, such as three radiopaque vision markers, to boost procedural visibility, improve deployment accuracy, and enable precise valve positioning during transcatheter implantation procedures. These three radiopaque vision markers are distinct reference points embedded within a medical device that amplify fluoroscopic visibility, aiding clinicians in accurately positioning and deploying the device during minimally invasive procedures. For instance, in January 2025, Abbott Laboratories, the US-based healthcare company, introduced Navitor Vision in India, which is the latest iteration of its transcatheter aortic valve implantation/replacement (TAVI/TAVR) system. This device is engineered to treat patients diagnosed with symptomatic severe aortic stenosis who present with high or extreme surgical risk. Navitor Vision incorporates three radiopaque vision markers for heightened visibility during implantation, features a dynamic sealing cuff to minimize blood leakage, and is deployed using Abbott’s FlexNav delivery system for accurate, minimally invasive valve placement. It presents a less invasive option compared to surgical aortic valve replacement, thereby enhancing outcomes and accessibility for high-risk patients.

Which Firms Are Competing In The Aortic Valve Replacement Devices Market?

Major companies operating in the aortic valve replacement devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Bracco SpA, Biotronik SE & Co. KG, LivaNova Plc, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Artivion Inc., LifeTech Scientific Corporation, TTK Healthcare Limited, Braile Biomedica, Venus Medtech Inc., SMT Pvt Ltd, JenaValve Technology Inc., Peijia Medical Limited, CryoLife Inc., CorLife, and Colibri Heart Valve LLC.

Access The Complete Aortic Valve Replacement Devices Market Report:

https://www.thebusinessresearchcompany.com/report/aortic-valve-replacement-devices-market-report

Which Regional Market Leads The Aortic Valve Replacement Devices Market?

North America was the largest region in the aortic valve replacement devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic valve replacement devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Aortic Valve Replacement Devices Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model